Theratechnologies Inc. Common Share Purchase Warrants

(TH.WT:PUR)

By |

Profile

Theratechnologies Inc is a specialty pharmaceutical company which addresses unmet medical needs of HIV patients. Its main product is Egrifta. The firm mainly operates in Canada and United States. It has only customer namely Rx Crossroad. The company earns revenue from the sale of goods, royalties and license fees and research services.

Contact Information

Website: www.theratech.com
Email: communications@theratech.com
Main Phone: +1 514 336-7800
Address: 2015 Peel Street
Address 2: 5th Flooor
State: QC
City / Town: Montreal
Country: CAN
Postal Code: H3A 1T8

Issuer Information

Exchange: TSX
CEO: Luc Tanguay
Employees: 84
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 2,300,000.00 EPS (TTM) N/A PE Ratio N/A Exchange TSX